TSGTF
Tsingtao Brewery Company Limited
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
5.63
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
5.63
Prev close
5.63
Day high
5.80
Day low
5.80
Volume
6.10K
Market cap
—
P/E (TTM)
—
52W range
5.21 – 7.14
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+1.99%
+3.4%
1M
+0.54%
-3.2%
3M
-13.38%
-16.5%
6M
-14.57%
-25.6%
YTD
-10.21%
-22.5%
1Y
-11.48%
-31.5%
3Y
-34.53%
-108.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $32.47B | $32.14B | $33.94B | $32.17B | +1.0% |
| Operating revenue | $32.47B | $32.14B | $33.94B | $32.17B | +1.0% |
| Cost of revenue | $18.89B | $19.21B | $20.82B | $20.32B | -1.7% |
| Gross profit | $13.59B | $12.93B | $13.12B | $11.85B | +5.1% |
| Research & development | $121.85M | $102.77M | $100.64M | $62.95M | +18.6% |
| Selling, general & admin | $2.10B | $2.25B | $2.32B | $1.99B | -6.8% |
| Total operating expense | $8.04B | $7.94B | $8.32B | $7.58B | +1.3% |
| Operating income | $5.54B | $4.99B | $4.80B | $4.27B | +11.1% |
| Net interest income | $394.68M | $570.32M | $459.98M | $408.60M | -30.8% |
| Pre-tax income | $6.29B | $5.88B | $5.75B | $5.01B | +7.0% |
| Tax provision | $1.57B | $1.39B | $1.40B | $1.20B | +13.2% |
| Net income | $4.59B | $4.34B | $4.27B | $3.71B | +5.6% |
| Net income to common | $4.59B | $4.34B | $4.27B | $3.71B | +5.6% |
| Basic EPS | 3.36 | 3.19 | 3.14 | 2.74 | +5.4% |
| Diluted EPS | 3.36 | 3.19 | 3.13 | 2.73 | +5.5% |
| EBIT | $6.30B | $5.90B | $5.76B | $5.02B | +6.8% |
| EBITDA | $7.56B | $7.09B | $6.90B | $6.11B | +6.6% |
| Basic shares | 1.36B | 1.36B | 1.36B | 1.36B | +0.2% |
| Diluted shares | 1.36B | 1.36B | 1.36B | 1.36B | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.86B | $17.98B | $19.28B | $17.85B | — | -28.5% |
| Cash & short-term investments | $19.09B | $20.00B | $21.21B | $20.54B | — | -4.6% |
| Accounts receivable | $126.98M | $102.42M | $100.39M | $119.60M | — | +24.0% |
| Inventory | $3.24B | $3.58B | $3.54B | $4.15B | — | -9.5% |
| Total current assets | $24.20B | $25.19B | $29.61B | $32.00B | — | -3.9% |
| Property, plant & equipment | $13.61B | $12.56B | $11.76B | $11.62B | — | +8.3% |
| Goodwill & intangibles | $3.90B | $3.99B | $3.80B | $3.86B | — | -2.2% |
| Total assets | $52.13B | $51.42B | $49.26B | $50.31B | — | +1.4% |
| Total current liabilities | $16.60B | $17.52B | $16.92B | $19.67B | — | -5.3% |
| Current debt | — | — | — | $225.41M | $245.78M | — |
| Total debt | $114.47M | $110.30M | $113.64M | $373.08M | — | +3.8% |
| Total liabilities | $20.62B | $21.56B | $21.00B | $24.04B | — | -4.4% |
| Retained earnings | $23.54B | $21.95B | $20.33B | $18.53B | — | +7.2% |
| Shareholder equity | $30.65B | $29.06B | $27.45B | $25.49B | — | +5.5% |
| Working capital | $7.60B | $7.67B | $12.69B | $12.33B | — | -0.8% |
| Net tangible assets | $26.75B | $25.07B | $23.65B | $21.63B | — | +6.7% |
| Shares issued | 1.36B | 1.36B | 1.36B | 1.36B | — | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $4.72B | $4.49B | $4.35B | $3.80B | +5.0% |
| Depreciation & amortisation | $1.26B | $1.19B | $1.14B | $1.08B | +5.7% |
| Stock-based compensation | $195.41K | $24.34M | $84.71M | $177.13M | -99.2% |
| Change in working capital | -$381.93M | $583.53M | -$1.58B | $878.67M | -165.5% |
| Operating cash flow | $4.59B | $5.15B | $2.78B | $4.88B | -10.9% |
| Capital expenditure | -$2.25B | -$2.14B | -$1.62B | -$1.78B | -5.2% |
| Investing cash flow | -$3.25B | -$7.42B | -$3.46B | -$2.20B | +56.3% |
| Dividends paid | -$2.99B | -$2.74B | -$2.48B | -$1.51B | -9.0% |
| Financing cash flow | -$3.10B | -$2.98B | -$2.87B | -$1.68B | -4.1% |
| Free cash flow | $2.34B | $3.01B | $1.16B | $3.10B | -22.4% |
| End cash position | $2.29B | $4.05B | $9.29B | $12.84B | -43.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $10.29B | $3.11B | — | $10.05B | $10.45B | $3.18B | +231.0% |
| Operating revenue | $10.29B | $3.11B | — | $10.05B | $10.45B | $3.18B | +231.0% |
| Cost of revenue | $5.89B | $2.34B | — | $5.44B | $6.10B | $2.34B | +151.8% |
| Gross profit | $4.40B | $768.04M | — | $4.60B | $4.35B | $833.91M | +472.4% |
| Research & development | $20.18M | $43.49M | — | $25.76M | $17.95M | $46.03M | -53.6% |
| Selling, general & admin | $1.54B | -$2.26B | $3.42B | -$701.41M | $1.64B | — | +168.2% |
| Total operating expense | $2.11B | $1.83B | — | $1.91B | $2.21B | $1.90B | +15.5% |
| Operating income | $2.28B | -$1.06B | — | $2.69B | $2.14B | -$1.06B | +315.0% |
| Net interest income | $71.58M | $80.65M | $105.20M | $102.25M | $106.59M | — | -11.2% |
| Pre-tax income | $2.45B | -$882.51M | — | $2.96B | $2.31B | -$849.43M | +377.6% |
| Tax provision | $617.64M | -$197.69M | — | $720.04M | $569.16M | -$211.02M | +412.4% |
| Net income | $1.80B | -$686.25M | — | $2.19B | $1.71B | -$644.91M | +362.3% |
| Net income to common | $1.80B | -$686.25M | — | $2.19B | $1.71B | -$644.91M | +362.3% |
| Basic EPS | 1.32 | — | — | — | 1.25 | — | — |
| Diluted EPS | 1.32 | — | — | — | 1.25 | — | — |
| EBIT | $2.45B | -$878.63M | $1.91B | $2.96B | $2.31B | — | +379.3% |
| EBITDA | $2.45B | -$878.63M | $1.91B | $2.96B | $2.31B | — | +379.3% |
| Basic shares | 1.36B | — | — | — | 1.36B | — | — |
| Diluted shares | 1.36B | — | — | — | 1.36B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.25B | $12.86B | $16.84B | $16.30B | $17.98B | +3.1% |
| Cash & short-term investments | $22.97B | $19.09B | $22.02B | $21.25B | $20.00B | +20.3% |
| Accounts receivable | $126.98M | $126.98M | $168.94M | $120.75M | $102.42M | -0.0% |
| Inventory | $2.33B | $3.24B | $2.07B | $2.27B | $3.58B | -27.9% |
| Total current assets | $26.93B | $24.20B | $25.23B | $24.66B | $25.19B | +11.3% |
| Property, plant & equipment | $13.70B | $13.61B | $12.79B | $12.66B | $12.56B | +0.6% |
| Goodwill & intangibles | $3.87B | $3.90B | $3.93B | $3.96B | $3.99B | -0.9% |
| Total assets | $53.37B | $52.13B | $52.37B | $51.29B | $51.42B | +2.4% |
| Total current liabilities | $15.79B | $16.60B | $17.63B | $15.73B | $17.52B | -4.9% |
| Total debt | $103.80M | $114.47M | $117.95M | $105.20M | $110.30M | -9.3% |
| Total liabilities | $20.08B | $20.62B | $21.60B | $19.73B | $21.56B | -2.6% |
| Retained earnings | $25.34B | $23.54B | $22.85B | $23.66B | $21.95B | +7.6% |
| Shareholder equity | $32.44B | $30.65B | $29.96B | $30.77B | $29.06B | +5.8% |
| Working capital | $11.14B | $7.60B | $7.60B | $8.92B | $7.67B | +46.5% |
| Net tangible assets | $28.57B | $26.75B | $26.03B | $26.82B | $25.07B | +6.8% |
| Shares issued | 1.36B | 1.36B | 1.36B | 1.36B | 1.36B | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$617.82M | -$691.43M | -$450.31M | -$499.02M | -$570.38M | +10.6% |
| Investing cash flow | -$2.99B | $1.43B | $1.91B | -$4.52B | $23.36M | -308.8% |
| Dividends paid | — | -$12.84K | -$1.55B | -$29.92K | -$3.38M | — |
| Financing cash flow | -$14.66M | -$15.04M | -$1.61B | -$14.78M | -$123.68M | +2.5% |
| Free cash flow | $2.38B | -$1.92B | $2.56B | $1.29B | -$1.65B | +224.2% |
| End cash position | $2.27B | $2.29B | $4.61B | $1.30B | $4.05B | -0.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.62
+0.20% from price
SMA 20
5.62
+0.23% from price
SMA 50
5.69
-1.10% from price
SMA 100
6.05
-6.95% from price
SMA 200
6.26
-10.01% from price
EMA 12
5.60
+0.62% from price
EMA 26
5.63
-0.00% from price
EMA 50
5.74
-1.91% from price
RSI (14)
49.8
Neutral
MACD (12,26,9)
-0.03
Hist 0.01
ATR (14)
0.15
2.59% of price
Realised vol 30D
39.0%
Annualised
Bollinger upper
5.98
20, 2σ
Bollinger lower
5.26
20, 2σ
50 / 200 cross
Death
5.69 vs 6.26
Trend bias
Below 200
-10.01%
Risk profile
Beta vs SPY
0.43
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
39.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.0%
Peak to trough
Max drawdown 5Y
-54.8%
Peak to trough
ATR 14
0.15
2.59% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.